Longeveron (LGVN) Asset Utilization Ratio (2023 - 2026)
Longeveron (LGVN) recorded quarterly Asset Utilization Ratio of 0.08 in Q1 2026, down 16.8% quarter-over-quarter from 0.09 in Q4 2025, and down 19.41% on a YoY basis from 0.1 in Q1 2025.
Longeveron (LGVN) Asset Utilization Ratio (2023 - 2026) Analysis & Trends
Longeveron's Asset Utilization Ratio history runs 4 years deep, the most recent figure standing at 0.08 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio fell 19.41% year-over-year to 0.08; the TTM figure through Mar 2026 stood at 0.08 (down 19.41% YoY), while the FY2025 annual figure was 0.07, down 47.33% from the prior year.
- Asset Utilization Ratio was 0.08 for Q1 2026 at Longeveron, down from 0.09 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.11 in Q2 2025 to a low of 0.04 in Q2 2023.
- Historically, Asset Utilization Ratio has averaged 0.08 across 4 years, with a median of 0.08 in 2024.
- The sharpest annual moves came in 2024 and 2026: Asset Utilization Ratio surged 129.22% in 2024, then decreased 19.41% in 2026.
- A 4-year view of Asset Utilization Ratio shows it stood at 0.06 in 2023, then surged by 44.17% to 0.09 in 2024, then advanced by 7.69% to 0.09 in 2025, then fell by 16.8% to 0.08 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.08 (Q1 2026), 0.09 (Q4 2025), and 0.09 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 0.55 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.60 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 1,422.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Longeveron | 20.35 Bn | 20.33 Bn | 264,000.00 | 0.08 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.08 |
| Dec 31, 2025 | 0.09 |
| Sep 30, 2025 | 0.09 |
| Jun 30, 2025 | 0.11 |
| Mar 31, 2025 | 0.10 |
| Dec 31, 2024 | 0.09 |
| Sep 30, 2024 | 0.08 |
| Jun 30, 2024 | 0.08 |
| Mar 31, 2024 | 0.09 |
| Dec 31, 2023 | 0.06 |
| Sep 30, 2023 | 0.05 |
| Jun 30, 2023 | 0.04 |
| Mar 31, 2023 | 0.04 |